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Available online 12 June 2015A 7-year-old girl, who was the first child of consanguineous
parents and was diagnosed with DOCK8-deficient (homo-
zygote large deletion, starts in exon 31 and extends at
least to exon 48 of DOCK8 gene; kindly provided by Prof Dr.
B. Grimbacher, Universitatsklinicum Freiburg, Freiburg,
Germany) hyper-IgE recurrent infection syndrome (ac-
cording to OMIM (Online Mendelian Inheritance in Man)
naming, phenotype MIM (Mendelian Inheritance in Man)
number #243700) 1 year ago when she presented with
herpes simplex virus lesions disseminated throughout her
body. Family history showed female and male patient
deaths due to severe herpes simplex virus and human
papillomavirus infections who died without receiving a
genetic diagnosis (Figure 1, III-5e7). The patient was
admitted with complaints of a swelling and wound on her
lip which was under antifungal and antibiotic prophylaxis.
The lip wound had begun as a herpetic lesion 7 months
previously, and intravenous acyclovir was applied for 50
days by a regional clinic after progression of the lesion
despite topical treatment. Foscarnet had been initiated* Corresponding author. Ankara Hematology Oncology Children’s
Training and Research Hospital, Pediatric Infectious Diseases
Department, Altındag 06110, Ankara, Turkey.
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response to systemic acyclovir treatment. The patient was
referred to our center for treatment and had no systemic
complaints. On physical examination, a mass lesion of
10 cm  8 cm originating from the upper lip with upward
extension was present (Figure 2A); but otherwise exami-
nation was normal. Hemoglobin was 8.3 g/dL (N: 11e14.5),
white blood cell count was 6800 mm3 (N: 3400e9500), and
platelets were 705,000 mm3 (N: 150,000e450,000). In a
peripheral blood smear, 18% eosinophils were detected
with equal proportions of neutrophils and lymphocytes.
Erythrocyte sedimentation rate was 39 mm/h (N: 0e20)
and C-reactive protein was 1.46 mg/dL (N: 0e0.8) with
normal blood biochemistry. Immunological tests results
during the first diagnosis revealed the following: immu-
noglobulin (Ig) G and IgA levels were within normal limits
for her age. However, IgM was 13 mg/dL (N for age:
78e261 mg/dL), IgE was 24,700 U/mL (N: <100 U/mL);
peripheral lymphocyte subpopulations using flow cytom-
etry showed normal CD3þ: 47% (1598 mm3), low
CD3þCD4þ: 17% (578 mm3), normal CD3þCD8þ: 27%
(918 mm3), normal CD19þ: 34% (1156 mm3), and normal
CD16þ56þ: 13% (442 mm3). Lymphocyte proliferation tests
(CD3þCD69þ) were normal compared to a control in the
presence of phytohemagglutinin, but low compared with
anti-CD3 (10% of healthy control) especially in CD8þCD69þby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 The pedigree of the patient’s family.
Figure 2 (A) The lesion of the patient on admission. (B) The appearance of the lesion after antiviral therapy and immuno-
modulatory therapy.
80 A. Metin et alwith anti-CD3 stimulations (20% of normal control). Anti-
body response to hepatitis B was normal, and iso-
hemagglutinins were low.
Following intravenous immunoglobulin infusion, inter-
feron-a was administered to the patient subcutaneously for
3 days per week, and foscarnet treatment was continued
for an additional 2 weeks. Malignancy was excluded using
imaging and laboratory tests. The lesion regressed signifi-
cantly under immunomodulatory and antiviral therapy
(Figure 2B). The patient was discharged with antibacterial
therapy, antifungal therapy, and regular monthly IV Ig
prophylaxis until bone marrow transplantation, along with
regular application of interferon-a. Hyper-IgE Syndrome is a
rare combined immunodeficiency characterized by sus-
ceptibility to viral infections, atopic eczema, defective T
cell activation, with high serum IgE.1,2 Autosomal recessive
form of disease is associated with mutations of DOCK8 or
TYK2.3 This case is noteworthy to emphasize the impor-
tance of supportive treatment to the immune system,
which is fundamental for the treatment of infections in
immunocompromised hosts.Conflict of interests
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